Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02792153

Estradiol and Fear Extinction in Anorexia Nervosa (AN)

Estradiol and Fear Extinction for Calorie-Dense Foods in Weight Restored Adult Women With Anorexia Nervosa (AN)

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether estrogen may help reduce fear of high calorie-density foods in weight-restored women with Anorexia Nervosa (AN).

Conditions

Interventions

TypeNameDescription
DRUGEstradiolAN participants will be prescribed 28 days of transdermal estradiol 0.1 mg/d (Days 1-28) plus 10 days (days 21-31) oral medroxyprogesterone 2.5 mg/d.

Timeline

Start date
2016-12-01
Primary completion
2018-08-22
Completion
2018-08-22
First posted
2016-06-07
Last updated
2018-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02792153. Inclusion in this directory is not an endorsement.

Estradiol and Fear Extinction in Anorexia Nervosa (AN) (NCT02792153) · Clinical Trials Directory